Riskpilot← Back to searchSign inGet full accessBellax AB
ABActiveOrg 5591228621Lövens Tä 18General medical practice activities · NACE 8621Est. 20171 employees
Revenue 2025
SEK 81K
-49% vs 2024
EBITDA margin
50.2%
-67% vs 2024
Equity ratio
91.4%
Financial strength
Net profit 2025
SEK 40K
-63% vs 2024
| Revenue | SEK 81K | -49% |
| EBITDA | SEK 40K | -67% |
| Net profit | SEK 40K | -63% |
| Total assets | SEK 600K | +3% |
| Equity | SEK 548K | +8% |
| Employees | 1 | — |
Legal name
Bellax AB
Org number
5591228621
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
25 augusti 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-07-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva medicinsk verksamhet, uthyrning av personal, utbildning, föreläsningar samt konsultation inom medicinska frågor, estetiska skönhetsbehandlingar, äga och förvalta aktier samt värdepapper, internethandel av solglasögon, konsulttjänster inom mark- och exploatering samt idka därmed förenlig verksamhet.
Address
Lövens Tä 18
Email
elias.wakie@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 156 | 70 | 192 | 159 | 81 |
| Staff expenses | — | −5 | −1 | −5 | −1 |
| EBITDA | 144 | 44 | 180 | 124 | 40 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 144 | 44 | 180 | 124 | 40 |
| Net financials | — | −2 | — | 11 | 10 |
| Profit before tax | 144 | 42 | 180 | 135 | 50 |
| Tax | −31 | −9 | −37 | −27 | −10 |
| Net profit | 113 | 33 | 143 | 108 | 40 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 464 | 307 | 484 | 581 | 600 |
| Equity | 425 | 258 | 401 | 508 | 548 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 39 | 49 | 83 | 73 | 51 |
| Total debt | 39 | 49 | 83 | 73 | 51 |
EBITDA margin
50.2%
This company
15.8%
Market median
+218% vs market
20212025
Equity ratio
91.4%
This company
38.2%
Market median
+139% vs market
20212025
Return on equity
7.2%
This company
18.4%
Market median
-61% vs market
20212025
Net profit margin
49.2%
This company
8.1%
Market median
+507% vs market
20212025
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20212025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-08-01 – 2025-07-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-08-01 – 2024-07-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-08-01 – 2023-07-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-08-01 – 2022-07-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-07-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bellax AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Camilla Sofie Maria Wakie | Deputy Board Member | 0 companies |
| Elias Teshome Wakie | Board of Directors | 0 companies |